Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
2,677
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Tofacitinib inhibits ox-LDL-induced adhesion of THP-1 monocytes to endothelial cells

Xiaoyang Yanga Department of Hematology, Affiliated Haikou Hospital Xiangya School Central South University and Haikou Municipal Municipal People’s Hospital, Haikou, Hainan, ChinaCorrespondence[email protected]
View further author information
,
Mengjie Wana Department of Hematology, Affiliated Haikou Hospital Xiangya School Central South University and Haikou Municipal Municipal People’s Hospital, Haikou, Hainan, ChinaView further author information
,
Zhiyong Chenga Department of Hematology, Affiliated Haikou Hospital Xiangya School Central South University and Haikou Municipal Municipal People’s Hospital, Haikou, Hainan, ChinaView further author information
,
Zhiming Wanga Department of Hematology, Affiliated Haikou Hospital Xiangya School Central South University and Haikou Municipal Municipal People’s Hospital, Haikou, Hainan, ChinaView further author information
&
Qingxia Wub Department of Nursing, Affiliated Haikou Hospital Xiangya School Central South University and Haikou Municipal Municipal People’s Hospital, Haikou, Hainan, ChinaView further author information
Pages 2775-2782 | Received 07 Nov 2018, Accepted 18 Dec 2018, Published online: 08 Jul 2019

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cristina Garufi, Mary Maclean, Massimo Gadina & Francesca Romana Spinelli. (2022) Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritis. Expert Review of Clinical Immunology 18:3, pages 309-319.
Read now
Fabiola Atzeni, Călin D. Popa, Valeria Nucera & Michael T. Nurmohamed. (2022) Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events. Expert Review of Clinical Immunology 18:3, pages 233-244.
Read now

Articles from other publishers (14)

Shanthi NarlaJonathan I. Silverberg. (2023) Safety of Oral Janus Kinase Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis. Dermatitis® 34:5, pages 366-386.
Crossref
Maria Pia Adorni, Bianca Papotti, Maria Orietta Borghi, Elena Raschi, Francesca Zimetti, Franco Bernini, Pier Luigi Meroni & Nicoletta Ronda. (2023) Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism. International Journal of Molecular Sciences 24:16, pages 12571.
Crossref
E. A. Zakharyan, E. S. Ageeva, Yu. I. Shramko, K. D. Malyi, A. K. Gurtovaya & R. E. Ibragimova. (2023) A modern view on the diagnostic role of endothelial dysfunction biomarkers and the possibilities of its correction. Complex Issues of Cardiovascular Diseases 11:4S, pages 194-207.
Crossref
Rebai Ben Ammar, Maged Elsayed Mohamed, Manal Alfwuaires, Sarah Abdulaziz Alamer, Mohammad Bani Ismail, Vishnu Priya Veeraraghavan, Ashok Kumar Sekar, Riadh Ksouri & Peramaiyan Rajendran. (2022) Anti-Inflammatory Activity of Geraniol Isolated from Lemon grass on Ox-LDL-Stimulated Endothelial Cells by Upregulation of Heme Oxygenase-1 via PI3K/Akt and Nrf-2 Signaling Pathways. Nutrients 14:22, pages 4817.
Crossref
Danfei Lou, Xinyue Xing & Yunyu Liang. (2022) Dendrobine modulates autophagy to alleviate ox‐LDL‐induced oxidative stress and senescence in HUVECs. Drug Development Research 83:5, pages 1125-1137.
Crossref
Zhoulan Zheng, Qianyu Guo, Dan Ma, Xuexue Wang, Chengqiang Zhang, Haiyao Wang, Liyun Zhang & Gailian Zhang. (2022) Related Risk Factors and Treatment Management of Psoriatic Arthritis Complicated With Cardiovascular Disease. Frontiers in Cardiovascular Medicine 9.
Crossref
Perle Totoson, Célian Peyronnel, Aurore Quirié, Martin Pédard, Marina Cefis, Laurent Bermont, Anne Prigent‐Tessier, Clément Prati, Maude Tournier, Daniel Wendling, Christine Marie & Céline Demougeot. (2021) Tofacitinib improved peripheral endothelial dysfunction and brain‐derived neurotrophic factor levels in the rat adjuvant‐induced arthritis model. Fundamental & Clinical Pharmacology 36:2, pages 363-374.
Crossref
Jing Yang & Xiaoli Xie. (2021) Tofacitinib protects intestinal epithelial cells against oxygen‑glucose deprivation/reoxygenation injury by inhibiting the JAK/STAT3 signaling pathway. Experimental and Therapeutic Medicine 22:4.
Crossref
Sarfaraz A. Hasni, Sarthak Gupta, Michael Davis, Elaine Poncio, Yenealem Temesgen-Oyelakin, Philip M. Carlucci, Xinghao Wang, Mohammad Naqi, Martin P. Playford, Rishi R. Goel, Xiaobai Li, Ann J. Biehl, Isabel Ochoa-Navas, Zerai Manna, Yinghui Shi, Donald Thomas, Jinguo Chen, Angélique Biancotto, Richard Apps, Foo Cheung, Yuri Kotliarov, Ashley L. Babyak, Huizhi Zhou, Rongye Shi, Katie Stagliano, Wanxia Li Tsai, Laura Vian, Nathalia Gazaniga, Valentina Giudice, Shajia Lu, Stephen R. Brooks, Meggan MacKay, Peter Gregersen, Nehal N. Mehta, Alan T. Remaley, Betty Diamond, John J. O’Shea, Massimo Gadina & Mariana J. Kaplan. (2021) Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus. Nature Communications 12:1.
Crossref
Zhengli Tan & Lei Li. (2021) Expression of LncRNA DLGAP1-AS1 in a Mouse Model of Atherosclerosis and Its Effect on Oxidized Low-Density Lipoprotein-Induced Vascular Endothelial Cell Injury. Journal of Biomaterials and Tissue Engineering 11:6, pages 1174-1180.
Crossref
Fabiola Atzeni, Javier Rodríguez-Carrio, Călin D. Popa, Michael T. Nurmohamed, Gabriella Szűcs & Zoltán Szekanecz. (2021) Cardiovascular effects of approved drugs for rheumatoid arthritis. Nature Reviews Rheumatology 17:5, pages 270-290.
Crossref
Diana Jhoseline Medina-Leyte, Oscar Zepeda-García, Mayra Domínguez-Pérez, Antonia González-Garrido, Teresa Villarreal-Molina & Leonor Jacobo-Albavera. (2021) Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. International Journal of Molecular Sciences 22:8, pages 3850.
Crossref
Wenhui Xie & Zhuoli Zhang. (2020) Tofacitinib in cardiovascular outcomes: friend or foe?. Rheumatology 59:8, pages 1797-1798.
Crossref
Thelvia I. Ramos Gómez & Jorge Roberto Toledo Alonso. (2020) LOX-1 en las afecciones cardiovasculares, perspectivas terapéuticas futuras. Bionatura 5:2.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.